High-dose versus low-dose losartan in patients with heart failure

被引：3
作者：
Kang, Seok-Min [1 ]
Oh, Jaewon [1 ]
Hong, Namki [1 ]
机构：
[1] Yonsei Univ, Med Ctr, Coll Med, Seoul 120752, South Korea
来源：
LANCET | 2010年 / 375卷 / 9720期
关键词：
ESSENTIAL-HYPERTENSION;
D O I：
10.1016/S0140-6736(10)60473-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1079 / 1079
页数：1
相关论文
共 4 条
[1]   Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging [J].
Anker, SD ;
Doehner, W ;
Rauchhaus, M ;
Sharma, R ;
Francis, D ;
Knosalla, C ;
Davos, CH ;
Cicoira, M ;
Shamim, W ;
Kemp, M ;
Segal, R ;
Osterziel, KJ ;
Leyva, F ;
Hetzer, R ;
Ponikowski, P ;
Coats, AJS .
CIRCULATION, 2003, 107 (15) :1991-1997
[2]   Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: Data from a multicenter, randomized, double-blind, 12-week trial [J].
Elliott, WJ ;
Calhoun, DA ;
DeLucca, PT ;
Gazdick, LP ;
Kerns, DE ;
Zeldin, RK .
CLINICAL THERAPEUTICS, 2001, 23 (08) :1166-1179
[3]   Effects of Losartan on renal function in patients with essential hypertension [J].
Fauvel, JP ;
Velon, S ;
Berra, N ;
Pozet, N ;
Madonna, O ;
Zech, P ;
Laville, M .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 28 (02) :259-263
[4]   Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial [J].
Konstam, Marvin A. ;
Neaton, James D. ;
Dickstein, Kenneth ;
Drexler, Helmut ;
Komajda, Michel ;
Martinez, Felipe A. ;
Riegger, Gunter A. J. ;
Malbecq, William ;
Smith, Ronald D. ;
Guptha, Soneil ;
Poole-Wilson, Philip A. .
LANCET, 2009, 374 (9704) :1840-1848
1